Oncoinv - Home

Multi cancer early detection test

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnosis is vital. Early diagnosis increases chances of survival and reduces the negative impact on quality of life. OncoInv offers OncoSeek®, a multi-cancer early detection blood test.

OncoSeek® is a low cost detection test for cancer

OncoSeek® is a software based early detection test, which analyses the concentrations of a selected number of protein tumor markers with a Machine Learning algorithm. It performs detection of 9 high-mortality cancers, calculating a Probability of Cancer score as wel as a predicted Tissue of Origin. OncoSeek® is scientifically validated, CE-marked and can be easily implemented as it uses existing medical infrastructure.

OncoSeek® can be used anywhere in the world by medical organisations who provide health services to the public.

Learn more about OncoSeek®

About Oncolnv

OncoInv is an initiative of Inspire2Live. It’s our mission to ensure that people worldwide have early access to treatment of cancer by means of early detection. OncoInv works together with SeekIn, the developer of OncoSeek®, to reach that mission.

Learn more about OncoInv

News & Updates

The University of Costa Rica launches its multi-cancer detection program using the OncoSeek® test

January 15th, 2026

OncoInv collaborates with the Universidad de Costa Rica (UCR) to support the introduction of the OncoSeek® multi-cancer detection test in Costa Rica. Through this collaboration, the test is now available within a public academic and clinical setting, marking an important step in expanding access to advanced cancer detection technologies in the region...

New publication adds to growing evidence base for OncoSeek® in multi-cancer early detection

December 17th, 2025

A recently published study in npj Precision Oncology adds further depth to the growing body of scientific evidence around multi-cancer early detection and the performance of OncoSeek®...

OncoInv signs distribution agreement for OncoSeek® in El Salvador

November 27th, 2025

OncoInv has signed a new distribution partnership with MaxBloch Clinical Laboratories in El Salvador, expanding the reach of its OncoSeek® multi-cancer detection blood test to Central America.